课题基金 / 基金详情

PRECLINICAL PHARMACOLOGY STUDIES OF ANTI-AIDS AGENTS

PRECLINICAL PHARMACOLOGY STUDIES OF ANTI-AIDS AGENTS
抗艾滋病药物的临床前药理学研究
批准号：
3615971
负责人：
JOHN MCCORMACK
金额：
$20.73万
依托单位：
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
依托单位国家：
美国
项目类别：
财政年份：
1988
资助国家：
美国
项目状态：
已结题
起止时间：
1988-09-15 至 1991-09-14
来源：
https://reporter.nih.gov/project-details/3615971
关键词：
antiAIDS agent dogs drug administration routes drug adverse effect drug metabolism immunopharmacology pharmacokinetics

项目摘要

项目成果

JOHN MCCORMACK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The major objective of these studies, in conjunction with the toxicology studies, is to determine whether viral inhibitory concentrations can be achieved without production of host toxicity, and the most effective route of administration of the agent, which will achieve the desired therapeutic concentration of the effective moiety.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOLOGICAL STUDIES OF ANTITUMOR & ANTI-HIV AGENTS
PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
PHARMACOLOGICAL STUDIES OF ANTI-TUMOR/HIV AGENTS
海外基金